Skip to Main content Skip to Navigation
Journal articles

Sucralose and Cardiometabolic Health: Current Understanding from Receptors to Clinical Investigations

Abstract : The excess consumption of added sugar is consistently found to be associated with weight gain, and a higher risk of type 2 diabetes mellitus, coronary heart disease, and stroke. In an effort to reduce the risk of cardiometabolic disease, sugar is frequently replaced by low- and null-calorie sweeteners (LCSs). Alarmingly, though, emerging evidence indicates that the consumption of LCSs is associated with an increase in cardiovascular mortality risk that is amplified in those who are overweight or obese. Sucralose, a null-caloric high-intensity sweetener, is the most commonly used LCS worldwide, which is regularly consumed by healthy individuals and patients with metabolic disease. To explore a potential causal role for sucralose in increased cardiovascular risk, this present review summarizes the preclinical and clinical data from current research detailing the effects of sucralose on systems controlling food intake, glucose homeostasis, and gut microbiota.
Document type :
Journal articles
Complete list of metadata

https://hal.inrae.fr/hal-03191902
Contributor : Sabine Julien <>
Submitted on : Wednesday, April 7, 2021 - 3:36:12 PM
Last modification on : Tuesday, May 11, 2021 - 11:36:30 AM

Identifiers

Collections

Citation

Sydney Risdon, Sylvain Battault, Alonso Romo-Romo, Matthieu Roustit, Loïc Briand, et al.. Sucralose and Cardiometabolic Health: Current Understanding from Receptors to Clinical Investigations. Advances in Nutrition, Oxford University Press, In press, pp.nmaa185. ⟨10.1093/advances/nmaa185⟩. ⟨hal-03191902⟩

Share

Metrics

Record views

34